FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
Go back to FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,388,474 | |||||
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.22 +0.01 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $3.85 | |||
| Open | $1.22 | 52 Week Low | $1.25 | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $-0.28 | |||
| Volume | 359,136 | |||||

